TAC-101 inhibits intrahepatic metastasis of orthotopically implanted murine hepatocellular carcinoma

Cancer Letters

Volumn 198, Issue 2, 2003, Pages 169-177

  Lee, Soo Jin ^a,b   Ohashi, Yasukata ^a   Sakurai, Hiroaki ^a   Saiki, Ikuo ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b Kyung Hee University   (South Korea)

Author keywords

AP 1; Hepatocellular carcinoma; Intrahepatic metastasis; TAC 101; u PA

Indexed keywords

4 [3,5 BIS(TRIMETHYLSILYL)BENZAMIDO]BENZOIC ACID; ANTINEOPLASTIC AGENT; BENZOIC ACID DERIVATIVE; MESSENGER RNA; TAC 101; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG; UROKINASE; UROKINASE RECEPTOR; PRIMER DNA; TRIMETHYLSILYL DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GRAFT; CANCER INHIBITION; CANCER INVASION; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; DISEASE MODEL; DOWN REGULATION; DRUG MECHANISM; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER METASTASIS; MOUSE; NONHUMAN; PHARMACODYNAMICS; PRIORITY JOURNAL; TUMOR CELL; TUMOR GROWTH; ANIMAL; CELL CULTURE; CELL DIVISION; CELL MOTION; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; DRUG EFFECT; DRUG IMPLANT; LIVER TUMOR; METABOLISM; METASTASIS; MOUSE STRAIN; NUCLEOTIDE SEQUENCE; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

MURINAE; RICKETTSIA SP. PAR;

ANIMALS; ANTICARCINOGENIC AGENTS; BASE SEQUENCE; BENZOATES; CARCINOMA, HEPATOCELLULAR; CELL DIVISION; CELL MOVEMENT; DISEASE MODELS, ANIMAL; DNA PRIMERS; DRUG IMPLANTS; LIVER NEOPLASMS; MICE; MICE, INBRED STRAINS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTOR AP-1; TRIMETHYLSILYL COMPOUNDS; TUMOR CELLS, CULTURED;

EID: 0142119397     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(03)00306-9     Document Type: Article

References (34)

1. Liotta L.A., Steeg P.S., Stetler-Stevenson W.G. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell. 64:1991;327-336.
2. Mignatti P., Rifkin D.B. Biology and biochemistry of proteinases in tumor invasion. Physiol. Rev. 73:1993;161-195.
3. Woodhouse E.C., Chuaqui R.F., Liotta L.A. General mechanisms of metastasis. Cancer. 80:1997;1529-1537.
4. Andreasen P.A., Kjoller L., Christensen L., Duffy M.J. The urokinase-type plasminogen activator system in cancer metastasis: a review. Int. J. Cancer. 72:1997;1-22.
5. Nieto-Rodriguez A., Hernandez-Pando R., Kershenobich D., Rodriguez-Fragoso L. Expression of urokinase-type plasminogen activator in an experimental model of hepatocarcinoma. Toxicology. 161:2001;13-23.
6. Nagao T., Inoue S., Goto S., Mizuta T., Omori Y., Kawano N., Morioka Y. Hepatic resection for hepatocellular carcinoma. Clinical features and long-term prognosis. Ann. Surg. 205:1987;33-40.
7. Mitsunobu M., Toyosaka A., Oriyama T., Okamoto E., Nakao N. Intrahepatic metastases in hepatocellular carcinoma: the role of the portal vein as an efferent vessel. Clin. Exp. Metastasis. 14:1996;520-529.
8. Yang J.N., Allan E.H., Anderson G.I., Martin T.J., Minkin C. Plasminogen activator system in osteoclasts. J. Bone Miner. Res. 12:1997;761-768.
9. Yamamoto H., Itoh F., Adachi Y., Sakamoto H., Adachi M., Hinoda Y., Imai K. Relation of enhanced secretion of active matrix metalloproteinases with tumor spread in human hepatocellular carcinoma. Gastroenterology. 112:1997;1290-1296.
10. Zheng Q., Tang Z.Y., Xue Q., Shi D.R., Song H.Y., Tang H.B. Invasion and metastasis of hepatocellular carcinoma in relation to urokinase-type plasminogen activator, its receptor and inhibitor. J. Cancer Res. Clin. Oncol. 126:2000;641-646.
11. Itoh T., Hayashi Y., Kanamaru T., Morita Y., Suzuki S., Wang W., Zhou L., Rui J.A., Yamamoto M., Kuroda Y., Itoh H. Clinical significance of urokinase-type plasminogen activator activity in hepatocellular carcinoma. J. Gastroenterol. Hepatol. 15:2000;422-430.
12. Murakami K., Wierzba K., Sano M., Shibata J., Yonekura K., Hashimoto A., Sato K., Yamada Y. TAC-101, a benzoic acid derivative, inhibits liver metastasis of human gastrointestinal cancer and prolongs the life-span. Clin. Exp. Metastasis. 16:1998;323-331.
13. Murakami K., Matsuura T., Sano M., Hashimoto A., Yonekura K., Sakukawa R., Yamada Y., Saiki I. 4-[3,5-Bis(trimethylsilyl)benzamido] benzoic acid (TAC-101) inhibits the intrahepatic spread of hepatocellular carcinoma and prolongs the life-span of tumor-bearing animals. Clin. Exp. Metastasis. 16:1998;633-643.
14. Sakukawa R., Murakami K., Ikeda T., Yamada Y., Saiki I. Effect of 4-[3,5-bis(trimethylsilyl)benzamido] benzoic acid (TAC-101) on the liver metastasis of colon 26-L5 carcinoma cells. Oncol. Res. 10:1998;287-293.
15. De Cesare D., Palazzolo M., Blasi F. Functional characterization of COM, a DNA region required for cooperation between AP-1 sites in urokinase gene transcription. Oncogene. 13:1996;2551-2562.
16. Ogawa K., Yamada Y., Kishibe K., Ishizaki K., Tokusashi Y. Beta-catenin mutations are frequent in hepatocellular carcinomas but absent in adenomas induced by diethylnitrosamine in B6C3F1 mice. Cancer Res. 59:1999;1833.
17. Sawada S., Murakami K., Yamaura T., Sakamoto T., Ogawa K., Tsukada K., Saiki I. Intrahepatic metastasis by orthotopic implantation of a fragment of murine hepatoma and its related molecules. Tumour. Biol. 22:2001;154-161.
18. Bernhardt G., Reile H., Birnbock H., Spruss T., Schonenberger H. Standardized kinetic microassay to quantify differential chemosensitivity on the basis of proliferative activity. J. Cancer Res. Clin. Oncol. 118:1992;35-43.
19. Saiki I., Murata J., Watanabe K., Fujii H., Abe F., Azuma I. Inhibition of tumor cell invasion by ubenimex (bestatin) in vitro. Jpn. J. Cancer Res. 80:1989;873-878.
20. Saito K., Oku T., Ata N., Miyashiro H., Hattori M., Saiki I. A modified and convenient method for assessing tumor cell invasion and migration and its application to screening for inhibitors. Biol. Pharm. Bull. 20:1997;345-348.
21. Krzesicki R.F., Winterrowd G.E., Brashler J.R., Hatfield C.A., Griffin R.L., Fidler S.F., Kolbasa K.P., Shull K.L., Richards I.M., Chin J.E. Identification of cytokine and adhesion molecule mRNA in murine lung tissue and isolated T cells and eosinophils by semi-quantitative reverse transcriptase-polymerase chain reaction. Am. J. Respir. Cell Mol. Biol. 16:1997;693-701.
22. Desai D., Michalak M., Singh N.K., Niles R.M. Inhibition of retinoic acid receptor function and retinoic acid-regulated gene expression in mouse melanoma cells by calreticulin. A potential pathway for cyclic AMP regulation of retinoid action. J. Biol. Chem. 271:1996;15153-15159.
23. Zhou L., Hayashi Y., Itoh T., Wang W., Rui J., Itoh H. Expression of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor, and plasminogen activator inhibitor-1 and -2 in hepatocellular carcinoma. Pathol. Int. 50:2000;392-397.
24. Silvestri I., Longanesi C.I., Franco P., Pirozzi G., Botti G., Stoppelli M.P., Carriero M.V. Engaged urokinase receptors enhance tumor breast cell migration and invasion by upregulating alpha(v)beta5 vitronectin receptor cell surface expression. Int. J. Cancer. 102:2002;562-571.
25. Lengyel E., Wang H., Stepp E., Juarez J., Wang Y., Doe W., Pfarr C.M., Boyd D. Requirement of an upstream AP-1 motif for the constitutive and phorbol ester-inducible expression of the urokinase-type plasminogen activator receptor gene. J. Biol. Chem. 271:1996;23176-23184.
26. Murakami K., Yamaura T., Suda K., Ohie S., Shibata J., Toko T., Yamada Y., Saiki I. TAC-101 (4-[3,5-bis(trimethylsilyl)benzamido]benzoic acid) inhibits spontaneous mediastinal lymph node metastasis produced by orthotopic implantation of Lewis lung carcinoma. Jpn. J. Cancer Res. 90:1999;1254-1261.
27. Sawada S., Murakami K., Yamaura T., Mitani N., Tsukada K., Saiki I. Therapeutic and analysis model of intrahepatic metastasis reflects clinical behavior of hepatocellular carcinoma. Jpn. J. Cancer Res. 93:2002;190-197.
28. Fujimoto K., Hosotani R., Doi R., Wada M., Lee J.U., Koshiba T., Miyamoto Y., Tsuji S., Nakajima S., Imamura M. Induction of cell-cycle arrest and apoptosis by a novel retinobenzoic-acid derivative, TAC-101, in human pancreatic-cancer cells. Int. J. Cancer. 81:1999;637-644.
29. Terranova V.P., Hujanen E.S., Martin G.R. Basement membrane and the invasive activity of metastatic tumor cells. J. Natl. Cancer Inst. 77:1986;311-316.
30. McCarthy J.B., Furcht L.T. Laminin and fibronectin promote the haptotactic migration of B16 mouse melanoma cells in vitro. J. Cell Biol. 98:1984;1474-1480.
31. Tsuchiya Y., Sawada S., Tsukada K., Saiki I. A new pseudo-peptide of Arg-Gly-Asp (RGD) inhibits intrahepatic metastasis of orthotopically implanted murine hepatocellular carcinoma. Int. J. Oncol. 20:2002;319-324.
32. Shaulian E., Karin M. AP-1 as a regulator of cell life and death. Nat. Cell Biol. 4:2002;E131-E136.
33. Westermarck J., Kahari V.M. Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J. 13:1999;781-792.
34. Minet E., Michel G., Mottet D., Piret J.P., Barbieux A., Raes M., Michiels C. c-JUN gene induction and AP-1 activity is regulated by a JNK-dependent pathway in hypoxic HepG2 cells. Exp. Cell Res. 265:2001;114-124.